急性缺血性脑卒中患者血浆PMP及EMP含量与预后的相关性

doi:10.6040/j.issn.1671-7554.0.2016.831

摘要/Abstract

摘要： 目的探讨急性缺血性脑卒中(AIS)患者血浆中血小板微粒体(PMP)和内皮细胞微粒体(EMP)水平与其预后的关系。方法以德州市人民医院神经内科2013年3月至2015年6月收治的56例AIS患者(AIS组)和40例体检者(对照组)为研究对象。对所有研究对象进行问卷调查并抽取5 mL静脉血,采用流式细胞仪检测PMP和EMP含量。对AIS组进行入院和出院NIHSS评分,据此将AIS组分为预后不良和预后良好两类。采用Logistic回归分析探讨影响AIS预后的危险因素。结果 AIS组PMP和EMP水平显著高于对照组(P<0.05)。AIS组中预后良好患者的 PMP和EMP水平显著低于预后不良的患者(P<0.05)。Logistic回归分析发现,糖尿病、高血压、PMP和EMP水平是影响AIS患者预后的独立预测因子。结论血浆PMP和EMP水平可能作为临床上评估AIS预后的指标。

关键词: 急性缺血性脑卒中, 内皮细胞微粒体, 预后, 血小板微粒体

Abstract: Objective To explore the relationship between circulating platelets microparticles(PMP)and endothelial microparticls(EMP)and prognosis in patients with acute ischemic stroke(AIS). Methods Fifty-six patients with AIS(AIS groups)hospitalized from March, 2013 to June, 2015 and 40 people who took health examination in Dezhou Peoples Hospital were selected(Control group), and all subjects were investigated to explore the risk factors of prognosis. Venous blood(5 mL)was extracted from each subject. Flow cytometry was used to detect the levels of PMP and EMP. Patients in AIS group were evaluated by the National Institutes of Health Stroke Scale(NIHSS)in admission and discharge, and were classified into two types, poor prognosis and favorable prognosis, according to the scores. Risk factors that affected prognosis were investigated by the Logistical regression analysis. Results The levels of PMP and EMP in AIS group were significantly higher than those in Control group(P<0.05). The levels of PMP and EMP in patients with favorable prognosis were significantly higher than those with poor prognosis(P<0.05). According to Logistical regression analysis, hypertension,diabetes and levels of circulating PMP and EMP were independent risk factors for the prognosis of AIS patients. Conclusion Circulating PMP and EMP levels are associated with AIS, which play important roles in the prognosis of AIS patients.

Key words: Platelets microparticles, Endothelial microparticles, Acute ischemic stroke, Prognosis

中图分类号:

R743

曲立新,时兴华,杜怡峰. 急性缺血性脑卒中患者血浆PMP及EMP含量与预后的相关性[J]. 山东大学学报（医学版）, 2016, 54(12): 32-36.

QU Lixin, SHI Xinghua, DU Yifeng. Relationship between circulating platelets microparticles and endothelial microparticls and prognosis in patients with acute ischemic stroke[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 32-36.

参考文献

[1] Shin SB, Kim TU, Hyun JK, et al. The prediction of clinical outcome using HbA1c in acute ischemic stroke of the deep branch of middle cerebral artery[J]. Ann Rehabil Med, 2015, 39(6):1011-1017.
[2] Lavallee PC, Labreuche J, Faille D, et al. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease[J]. Cerebrovasc Dis, 2013, 36(2):131-138.
[3] Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay[J]. Thromb Res, 2011, 127(4):370-377.
[4] Csongradi E, Nagy B Jr, Fulop T, et al. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients[J]. Thromb Haemost, 2011, 106(4):683-692.
[5] Schiro A, Wilkinson FL, Weston R, et al. Endothelial microparticles as conveyors of information in atherosclerotic disease[J]. Atherosclerosis, 2014, 234(2): 295-302.
[6] Chen Y, Xiao Y, Lin Z, et al. The role of circulating platelets microparticles and platelet parameters in acute ischemic stroke patients[J]. J Stroke Cerebrovasc Dis, 2015, 24(10):2313-2320.
[7] 孔德燕. 腔隙性脑梗死患者脑微出血与循环内皮微粒的相关性研究[J]. 中华老年心脑血管病杂志, 2015, 17(6): 610-612. KONG Deyan. Correlation between cerebral microbleeds and circulating endothelial microparticles in lacunar stroke patients[J].Chin J Geriatr Heart Brain Vessel Dis, 2015, 17(6): 610-612.
[8] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学,2011,35(14):4013-4017.
[9] Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment[J]. Stroke, 1993, 24(1):35-41.
[10] Burnouf T, Goubran HA, Chou ML, et al. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine[J]. Blood Rev, 2014, 28(4):155-166.
[11] Chen J, Chen S, Chen Y, et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage[J]. Am J Physiol Endocrinol Metab, 2011, 301(1): E62-71.
[12] Miedema I, Uyttenboogaart M, Koch M, et al. Lack of association between serum uric acid levels and outcome in acute ischemic stroke[J]. J Neurol Sci, 2012, 319(1-2): 51-55.
[13] Ferraris VA. Microparticles: the good, the bad, and the ugly[J]. J Thorac Cardiovasc Surg, 2015,149(1): 312-313.
[14] Nadaud S, Poirier O, Girerd B, et al. Small plateletmicroparticle levels are increased in pulmonary arterial hypertension[J]. Eur J Clin Invest, 2013, 43(1): 64-71.
[15] Kumral E, Saruhan G, Aktert D, et al. Association of hyperhomocysteinemia with stroke recurrence after initial stroke[J]. J Stroke Cerebrovasc Dis, 2016, 25(8):2047-2054.
[16] Gremmel T, Ay C, Riedl J, et al. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis[J]. Thromb Haemost, 2016, 115(3):615-621.
[17] Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes[J]. Stroke, 2003, 34(9): 2132-2137.
[18] Ribo M, Flores A, Mansilla E, et al. Age-adjusted infarct volume threshold for good outcome after endovascular treatment[J]. J Neurointerv Surg, 2014, 6(6): 418-422.
[19] Tikhonoff V, Zhang H, Richart T, et al. Blood pressure as a prognostic factor after acute stroke[J]. Lancet Neurol, 2009, 8(10): 938-948.
[20] Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial[J]. Stroke, 2008, 39(10): 2749-2755.

相关文章 15

[1]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[2]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[3]	王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[4]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[5]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[6]	杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[7]	刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[8]	陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[9]	郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16.
[10]	魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[11]	刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[12]	杨雪彦,吴寅平,吕丽,赵泽华,马行宇,李凤彩,王凯,范玉琛. 单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值[J]. 山东大学学报 (医学版), 2024, 62(3): 61-69.
[13]	刁玉洁,林琳,李文瑄,王洲洋,江蓓,胡迎迎,刘广义. NPR预测ANCA相关血管炎不良肾脏预后及其协同多因素优化模型[J]. 山东大学学报 (医学版), 2024, 62(2): 60-68.
[14]	宋兆录,董正璇,彭传真,黄彩娜,胡克清,黄永胜,阎磊. 肾透明细胞癌中预后相关RNA编辑位点的筛选[J]. 山东大学学报 (医学版), 2023, 61(9): 69-78.
[15]	刘艳,冷珊珊,夏晓娜,董昊,黄陈翠,孟祥水. 基于影像组学参数评估376例幕上自发性脑出血患者的功能状态[J]. 山东大学学报 (医学版), 2023, 61(5): 59-67.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed